Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
7,840.00
+40.00 (0.51%)
Apr 10, 2026, 3:30 PM KST
5.95% (1Y)
| Market Cap | 181.41B -17.8% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 62,112 |
| Average Volume | 87,632 |
| Open | 7,800.00 |
| Previous Close | 7,800.00 |
| Day's Range | 7,690.00 - 7,920.00 |
| 52-Week Range | 6,970.00 - 12,670.00 |
| Beta | 0.90 |
| RSI | 44.12 |
| Earnings Date | Nov 11, 2025 |